Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing?remitting multiple sclerosis: The TERICAM study - Martínez-Ginés ML; García-Domínguez JM; Cuello JP; Meca-Lallana V; Aguirre C; Costa-Frossard L; Monreal E; de la Maza SS; Salgado-Cámara P; Labiano-Fontcuberta A; Fernández-Cabredo L; Aladro-Benito Y; et al. (Neurology Perspectives, 2023)